Overview

Botulinum Toxin for Erectile Dysfunction

Status:
Completed
Trial end date:
2019-01-10
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of intra-cavernosal Botulinum toxin injection as an alternative line of treatment in patients with erectile dysfunction - not responding to oral PDE5i - through cavernosal smooth muscle relaxation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cairo University
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A